GO:0051902 negative regulation of mitochondrial depolarization: Mitochondrial Homeostasis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051902 describes any process that stops, prevents, or reduces the frequency, rate or extent of the change in mitochondrial membrane potential from negative to positive.
• The PINK1/Parkin axis is the best-characterized mechanism that preserves mitochondrial membrane potential and prevents depolarization-dependent mitophagy.
• Kinases such as EIF2AK1/HRI act as negative regulators of PINK1 mitophagy signaling, thereby influencing mitochondrial depolarization thresholds.
• RAB7A phosphoswitches and Rubicon homology proteins coordinate Parkin-dependent mitophagy and mitochondrial quality control.
• CASP9 is essential for autophagosome maturation and mitochondrial homeostasis, linking apoptotic machinery to depolarization control.
• Dysregulated negative regulation of mitochondrial depolarization contributes to T cell exhaustion, Alzheimer's disease, and triple-negative breast cancer.
Description
Mitochondrial membrane potential is a central bioenergetic parameter that reflects the proton-motive force across the inner mitochondrial membrane. Under stress, mitochondria can undergo depolarization, a shift from a negative to a positive membrane potential that serves as a signal for mitophagy and cell death. GO:0051902, negative regulation of mitochondrial depolarization, encompasses the cellular processes that oppose this transition and preserve mitochondrial function. Understanding this term is critical because the balance between depolarization and its negative regulation determines whether a cell survives, repairs damaged mitochondria, or commits to apoptosis.
negative regulation of mitochondrial depolarization At A Glance
| GO ID | GO:0051902 |
|---|---|
| GO term | negative regulation of mitochondrial depolarization |
| Ontology | biological_process |
| Synonym | down regulation of mitochondrial depolarization; down-regulation of mitochondrial depolarization; downregulation of mitochondrial depolarization; inhibition of mitochondrial depolarization |
| Major function | Preservation of mitochondrial membrane potential by preventing or reducing depolarization |
| Key regulators | PINK1, Parkin, EIF2AK1/HRI, RAB7A, Rubicon homology proteins, CASP9, Tom7, OMA1 |
| Associated diseases | T cell exhaustion, Alzheimer's disease, triple-negative breast cancer |
| Research methods | Live-cell imaging with TMRM, mitophagy flux assays, CRISPR knockout/knock-in, kinome screening |
What Is GO:0051902?
GO:0051902 is a biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of the change in the membrane potential of the mitochondria from negative to positive. In practical terms, it includes molecular events that stabilize the inner mitochondrial membrane potential, delay the onset of depolarization, or accelerate repolarization after transient stress. This regulation is essential for maintaining ATP production, calcium buffering, and mitochondrial quality control.
Why Is negative regulation of mitochondrial depolarization Important in Cell Biology?
Negative regulation of mitochondrial depolarization is a decisive checkpoint in mitochondrial quality control and cell fate. When this regulation fails, excessive depolarization triggers PINK1/Parkin-dependent mitophagy, metabolic collapse, and apoptosis, contributing to neurodegeneration, immune exhaustion, and chemoresistance in cancer. Conversely, enhancing this regulation can protect neurons, sustain T cell function, and sensitize tumors to therapy, making it a high-value target for basic and translational research.
• Maintains ATP production and metabolic homeostasis by preserving the proton-motive force.
• Controls the threshold for PINK1/Parkin-dependent mitophagy and mitochondrial clearance.
• Prevents inappropriate apoptosis by limiting cytochrome c release and caspase activation.
• Supports T cell effector function and prevents exhaustion in chronic infection and cancer.
• Protects neurons from calcium overload and ER-mitochondria stress in Alzheimer's disease.
• Modulates chemosensitivity in triple-negative breast cancer.
• Integrates with integrated stress response kinases such as EIF2AK1/HRI.
• Coordinates with endolysosomal trafficking via RAB7A and Rubicon homology proteins.
• Regulates mitochondrial import and turnover through Tom7 and OMA1.
• Provides a druggable node for therapies targeting mitochondrial dysfunction.
What Happens During negative regulation of mitochondrial depolarization?
Sensing mitochondrial stress and membrane potential
In simple terms: The cell first detects when mitochondria are losing their electrical charge.
Mitochondrial depolarization is sensed by PINK1, a kinase that accumulates on the outer mitochondrial membrane when the membrane potential is lost. Under normal conditions, PINK1 is imported and degraded, but depolarization stabilizes it and initiates downstream signaling. Tom7 and OMA1 reciprocally regulate PINK1 import and activation, providing a first layer of negative regulation that prevents unnecessary mitophagy.
PINK1/Parkin-dependent mitophagy signaling
In simple terms: When damage is severe, the cell tags mitochondria for destruction, but negative regulators can pause this process.
PINK1 phosphorylates ubiquitin and Parkin, activating Parkin's E3 ligase activity and amplifying mitophagy. Negative regulation of mitochondrial depolarization can occur through kinases such as EIF2AK1/HRI, which was identified as a negative regulator of PINK1 mitophagy signaling in a kinome screen. Ubiquitin signaling in PINK1/Parkin-dependent mitophagy is tightly controlled to avoid excessive mitochondrial removal.
RAB7A phosphoswitch and Rubicon homology proteins
In simple terms: A molecular switch on mitochondria helps decide whether they are cleared or preserved.
RAB7A undergoes phosphorylation that coordinates Rubicon homology protein regulation of Parkin-dependent mitophagy. This phosphoswitch modulates the balance between mitochondrial preservation and degradation, thereby influencing the negative regulation of depolarization.
CASP9 and autophagosome maturation
In simple terms: Apoptotic proteins also help recycle damaged mitochondria, linking cell death and survival.
CASP9 is essential for autophagosome maturation through regulation of mitochondrial homeostasis. Loss of CASP9 impairs autophagic flux and alters mitochondrial membrane potential dynamics, showing that apoptotic machinery intersects with negative regulation of depolarization.
Proteasome-guided haem signaling in T cell exhaustion
In simple terms: Immune cells use mitochondrial quality control to stay active.
A proteasome-guided haem signaling axis contributes to T cell exhaustion by modulating mitochondrial function. This axis influences mitochondrial depolarization and its negative regulation, linking mitochondrial membrane potential control to immune cell fate.
Key Genes Involved in GO:0051902 negative regulation of mitochondrial depolarization
The following genes and proteins are experimentally implicated in the negative regulation of mitochondrial depolarization or in the opposing depolarization-dependent pathways that define this process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PINK1 | Stabilized on depolarized mitochondria; initiates mitophagy | Core sensor of mitochondrial depolarization |
| PRKN (Parkin) | E3 ubiquitin ligase amplifying mitophagy | Central effector of depolarization-induced mitophagy |
| EIF2AK1 (HRI) | Integrated stress response kinase; negative regulator of PINK1 mitophagy | Kinome screen hit controlling depolarization thresholds |
| RAB7A | Phosphoswitch coordinating Rubicon homology proteins | Regulates Parkin-dependent mitophagy |
| CASP9 | Caspase essential for autophagosome maturation | Links apoptosis to mitochondrial homeostasis |
| TOM7 | Regulates mitochondrial import of PINK1 | Reciprocal role with OMA1 in PINK1 activation |
| OMA1 | Protease activated by depolarization | Cleaves PINK1 and modulates mitophagy |
| Rubicon homology proteins | Modulate Parkin-dependent mitophagy | Downstream of RAB7A phosphoswitch |
| Haem signaling proteins | Proteasome-guided haem axis in T cells | Contributes to T cell exhaustion via mitochondrial control |
| ER-calcium regulators | Maintain ER-mitochondria calcium transfer | Dysregulated in Alzheimer's neurons |
| Mitochondrial-targeted gene therapy vectors | Deliver therapeutic genes to mitochondria | Used in triple-negative breast cancer models |
| Chemotherapy response modifiers | Modulate mitochondrial depolarization under drug stress | Relevant to TNBC treatment |
| Autophagy machinery (ATG proteins) | Execute autophagosome formation | Interact with CASP9 and mitochondrial homeostasis |
| Ubiquitin signaling components | Regulate PINK1/Parkin pathway | Targets for modulating mitophagy |
| Integrated stress response kinases | Sense mitochondrial stress | Include EIF2AK1/HRI |
| Calcium channels (ER-mitochondria) | Control calcium transfer | Implicated in Alzheimer's disease |
| Proteasome subunits | Degrade ubiquitinated proteins | Linked to haem signaling in T cells |
How Is negative regulation of mitochondrial depolarization Regulated?
Negative regulation of mitochondrial depolarization is controlled at multiple levels. The integrated stress response kinase EIF2AK1/HRI acts as a negative regulator of PINK1 mitophagy signaling, thereby raising the threshold for depolarization-induced clearance. Ubiquitin signaling in PINK1/Parkin-dependent mitophagy provides reversible post-translational control. RAB7A phosphorylation acts as a phosphoswitch that coordinates Rubicon homology protein activity and Parkin-dependent mitophagy. Tom7 and OMA1 reciprocally regulate PINK1 import and activation, adding a mitochondrial import checkpoint. Finally, proteasome-guided haem signaling in T cells links metabolic stress to mitochondrial depolarization control.
negative regulation of mitochondrial depolarization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PINK1 | Parkinson's disease, mitophagy dysfunction | PINK1 knockout neurons, patient iPSCs |
| PRKN | Parkinson's disease, early-onset | Parkin knockout mice, CRISPR knock-in |
| EIF2AK1 (HRI) | Integrated stress response, mitophagy regulation | HRI knockout cell lines, kinome screens |
| CASP9 | Autophagy and apoptosis crosstalk | CASP9 knockout cells, autophagosome assays |
| RAB7A | Endolysosomal trafficking, mitophagy | RAB7A phosphomutant knock-in cells |
T cell exhaustion and immune dysfunction
Chronic antigen stimulation drives T cell exhaustion, a state characterized by progressive loss of effector function. A proteasome-guided haem signaling axis contributes to T cell exhaustion by modulating mitochondrial function and depolarization. Negative regulation of mitochondrial depolarization may preserve T cell fitness and improve immunotherapy outcomes.
Alzheimer's disease and neurodegeneration
Mitochondrial dysfunction mediated by ER-calcium dysregulation occurs in neurons derived from Alzheimer's disease patients. Excessive mitochondrial depolarization and impaired negative regulation contribute to synaptic loss and neuronal death, making this pathway a therapeutic target.
Triple-negative breast cancer and chemoresistance
Combining mitochondrial-targeted gene therapy with chemotherapy has been explored to treat triple-negative breast cancer. Mitochondrial depolarization status influences drug response, and negative regulators of depolarization may modulate chemosensitivity.
From negative regulation of mitochondrial depolarization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance mitochondrial depolarization? | CRISPR knockout cell line + TMRM imaging |
| Does a specific phosphorylation site regulate mitophagy? | Point-mutation knock-in (e.g., RAB7A phosphomutant) |
| Can a protective gene prevent depolarization? | Overexpression cell model + stress challenge |
| Where does a protein localize during depolarization? | Tagged knock-in (e.g., GFP-PINK1) + live imaging |
| Which kinases modulate PINK1 mitophagy? | CRISPR library screening / kinome screening |
| Does a mutation affect T cell exhaustion? | Primary T cell knockout + chronic stimulation |
How to Study the negative regulation of mitochondrial depolarization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| TMRM / JC-1 imaging | Mitochondrial membrane potential | Live-cell depolarization assays |
| mt-Keima flux | Mitophagy flux | Distinguishing depolarization from clearance |
| CRISPR knockout screening | Gene requirement for depolarization | Identifying negative regulators |
| Phosphoproteomics | Phosphorylation changes | Mapping RAB7A phosphoswitch |
| Ubiquitin proteomics | Ubiquitination of mitochondrial proteins | PINK1/Parkin substrate discovery |
| Immunofluorescence | Protein localization | PINK1 accumulation on depolarized mitochondria |
| Seahorse respirometry | Oxygen consumption rate | Mitochondrial function under stress |
| Autophagosome maturation assays | LC3 flux | CASP9-dependent autophagy |
Live-cell imaging of mitochondrial membrane potential
TMRM or JC-1 dyes allow real-time measurement of mitochondrial depolarization in live cells. Combining these dyes with CRISPR knockout or knock-in models reveals how candidate genes regulate membrane potential dynamics.
Mitophagy flux assays
Mitophagy flux can be measured using mt-Keima or mito-QC reporters. These assays distinguish between mitochondrial delivery to lysosomes and alterations in depolarization thresholds, providing functional readouts for negative regulators.
CRISPR library screening and kinome screening
Pooled CRISPR knockout libraries and kinome-focused screens identify negative regulators of PINK1 mitophagy signaling. Such screens have successfully uncovered EIF2AK1/HRI as a modulator of depolarization.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify ubiquitination and phosphorylation events on mitochondria during depolarization. This approach maps signaling nodes such as RAB7A phosphoswitches and Parkin substrates.
How CRISPR Can Be Used to Study GO:0051902 negative regulation of mitochondrial depolarization
Knockout
CRISPR knockout of candidate genes such as PINK1, PRKN, or EIF2AK1 allows researchers to test whether loss of function accelerates or delays mitochondrial depolarization. Knockout cell lines are essential for establishing causality in this pathway.
Point Mutation
Point-mutation knock-in models, such as phospho-dead or phospho-mimetic RAB7A, dissect the role of specific residues in regulating Parkin-dependent mitophagy and depolarization thresholds.
Knock-in
Tagged knock-in of PINK1 or Parkin with fluorescent or affinity tags enables real-time tracking of protein localization and interactions during depolarization.
Overexpression
Overexpression of protective genes, such as mitochondrial-targeted therapeutic constructs, can test whether enhancing negative regulation of depolarization improves cell survival under stress, as explored in triple-negative breast cancer models.
How EDITGENE Supports negative regulation of mitochondrial depolarization Research
Researchers studying negative regulation of mitochondrial depolarization-related genes often need to determine whether a candidate gene is causally involved in preserving membrane potential or modulating mitophagy thresholds. Rigorous causal inference requires well-controlled genetic models, including knockout, point-mutation, knock-in, and overexpression cell lines, as well as unbiased screening approaches.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitochondrial depolarization research.
Frequently Asked Questions About negative regulation of mitochondrial depolarization
What is negative regulation of mitochondrial depolarization?
It is the biological process that stops, prevents, or reduces the change in mitochondrial membrane potential from negative to positive, as defined by GO:0051902.
What genes are involved in negative regulation of mitochondrial depolarization?
Key genes include PINK1, PRKN (Parkin), EIF2AK1 (HRI), RAB7A, CASP9, TOM7, and OMA1, all implicated in mitophagy and mitochondrial quality control.
How is mitochondrial depolarization measured?
Common methods include TMRM or JC-1 live-cell imaging, mt-Keima mitophagy flux assays, and Seahorse respirometry.
What is the role of PINK1 in mitochondrial depolarization?
PINK1 is stabilized on depolarized mitochondria and initiates Parkin-dependent mitophagy, making it a central sensor of membrane potential loss.
How does EIF2AK1/HRI regulate mitophagy?
EIF2AK1/HRI acts as a negative regulator of PINK1 mitophagy signaling, raising the threshold for depolarization-induced clearance.
What diseases are linked to mitochondrial depolarization?
T cell exhaustion, Alzheimer's disease, and triple-negative breast cancer have been associated with dysregulated mitochondrial depolarization.
Can CRISPR be used to study mitochondrial depolarization?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models are widely used to dissect genes controlling depolarization.
What is the RAB7A phosphoswitch?
RAB7A phosphorylation coordinates Rubicon homology protein regulation of Parkin-dependent mitophagy, influencing depolarization thresholds.
How does CASP9 affect mitochondrial homeostasis?
CASP9 is essential for autophagosome maturation and regulates mitochondrial homeostasis, linking apoptosis to depolarization control.
What is the relationship between Tom7 and OMA1?
Tom7 and OMA1 reciprocally regulate mitochondrial import and activation of PINK1, modulating the response to depolarization.
Conclusion
GO:0051902, negative regulation of mitochondrial depolarization, is a critical biological process that preserves mitochondrial function and cell fate decisions. The PINK1/Parkin axis, EIF2AK1/HRI, RAB7A, CASP9, and Tom7/OMA1 form an integrated network that controls whether mitochondria are repaired or cleared. Dysregulation of this process contributes to T cell exhaustion, Alzheimer's disease, and triple-negative breast cancer, making it a promising target for therapeutic intervention.
References
- 1. Xu Y et al.. 2026. Proteasome-guided haem signalling axis contributes to T cell exhaustion.. Nature 653(8114):548-557 PMID: 41851457
- 2. Okatsu K et al.. 2026. Ubiquitin signaling in PINK1/Parkin-dependent mitophagy.. J Biochem 179(3):145-154 PMID: 41368810
- 3. Singh PK et al.. 2025. Kinome screening identifies integrated stress response kinase EIF2AK1/HRI as a negative regulator of PINK1 mitophagy signaling.. Sci Adv 11(19):eadn2528 PMID: 40344059
- 4. Tudorica DA et al.. 2024. A RAB7A phosphoswitch coordinates Rubicon Homology protein regulation of Parkin-dependent mitophagy.. J Cell Biol 223(7) PMID: 38728007
- 5. An HK et al.. 2020. CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis.. Autophagy 16(9):1598-1617 PMID: 31818185
- 6. Sekine S et al.. 2019. Reciprocal Roles of Tom7 and OMA1 during Mitochondrial Import and Activation of PINK1.. Mol Cell 73(5):1028-1043.e5 PMID: 30733118
- 7. Mustaly-Kalimi S et al.. 2025. Mitochondrial dysfunction mediated by ER-calcium dysregulation in neurons derived from Alzheimer's disease patients.. Acta Neuropathol Commun 13(1):165 PMID: 40721842
- 8. Varadkar T et al.. 2025. Combine mitochondrial-targeted gene therapy and chemotherapy to treat triple-negative breast cancer.. J Exp Clin Cancer Res 44(1):328 PMID: 41462289
